ADHD drugs shortage: what's behind it?
Supply chain issues and 'tripling' of prescriptions concerns GPs as problems getting medication become 'desperate'
Doctors in the UK are increasingly concerned that a global shortage of ADHD drugs is leading to children going without medication and missing school, and adults self-medicating with alcohol instead.
With record numbers of people being diagnosed with ADHD, two-thirds of parents with affected children are facing problems getting medication, with some saying their children are then unable to concentrate in lessons or have to take days off, according to a survey by the charity ADHD UK.
GPs, meanwhile, are warning that "desperate" adults with ADHD are resorting to alcohol, "acting out of frustration and anger" at the medication shortage, said Sky News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
How common is ADHD?
It was long assumed that between 5% and 6% of children have ADHD but "the rates, in practice, are often higher", said Sven Bölte, a professor of child and adolescent psychiatric science at Sweden's Karolinska Institutet, on The Conversation.
The US Centers for Disease Control and Prevention estimated the rate at 11.4% of US children in 2022, while the Swedish Board of Health and Welfare forecast that the rates will eventually plateau at 15% for boys and 11% for girls.
The latest NHS figures show that there are a 230,000 people in England taking medication to treat ADHD, "including 110,000 children and teenagers", said The Times. But the true number of people in England affected by some form of ADHD "might be as many as 2.2 million", said the health think tank, the Nuffield Trust.
Why the shortage in medication?
There are "five types of medicine licensed for the treatment of ADHD in the UK", said The Times, the "most common of which is methylphenidate", sold under the brand names Concerta and Ritalin.
Most types of ADHD medication have been affected by global shortages that began in September last year and are caused by "manufacturing issues, supply chain problems and an increase in demand", said Sky News.
The rising demand is key. Prescriptions have "tripled" over the past decade "as the condition has become more widely diagnosed", said The Times. The "main increase" in diagnoses is among "young women aged 25 to 40", said The Guardian.
ADHD is a "widespread" topic on social media globally, with #ADHD attracting "tens of billions of hits" on TikTok. And, according to NHS England, ADHD was the second most-viewed health condition on the NHS website in 2023, after Covid-19, with 4.3 million page views.
Are we over-treating ADHD?
Part of the problem is that, currently, ADHD is treated as "something you either have or you don't", said The Economist. Treating diagnosed people as "ill" puts a strain on healthcare and special-needs-education systems, while forcing people to "fit in with normal", which can "cause anxiety and depression".
But this "binary view" of ADHD is "no longer supported by science". Researchers have realised that there is no such thing as the "ADHD brain". The characteristics around which an ADHD diagnosis is made – attention problems, impulsivity, difficulty organising daily life – span a "wide spectrum of severity, much like ordinary human traits".
For those at the severe end of the spectrum, "medication and therapy can be crucial for finishing school or holding on to a job" but, for most people with ADHD, the symptoms are "mild enough to disappear when their environment plays to their strengths".
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Italy's prisons crisis
Under the Radar Severe overcrowding, dire conditions and appalling violence have brought the Italian carceral system to boiling point
By Rebecca Messina, The Week UK Published
-
The potential effects of Israel's ceasefire with Hezbollah
THE EXPLAINER With the possibility of a region-wide war fading, the Palestinian militant group Hamas faces increased isolation and limited options
By Rafi Schwartz, The Week US Published
-
Sudoku medium: December 9, 2024
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Polycystic ovary syndrome: what it is, how it's treated and why it's often misunderstood
The Explainer PCOS affects millions, but there is still no cure outside of treating symptoms separately
By Theara Coleman, The Week US Published
-
The growing list of conditions weight-loss drugs could help with
The Explainer Ozempic and similar drugs have been linked to possibly helping diseases beyond diabetes and obesity. Are they miracle drugs?
By Theara Coleman, The Week US Published
-
Should blood donors be paid?
The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
By The Week UK Published
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis users
The Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
By Theara Coleman, The Week US Published
-
Pink cocaine: the new drug cocktail responsible for an increasing number of deaths
In the Spotlight The substance has been linked to the death of Liam Payne and named in a lawsuit against Sean 'Diddy' Combs
By Justin Klawans, The Week US Published
-
Why scurvy is on the rise
The Explainer Cost of living and poor dietary choices fuelling a potential resurgence of condition associated with the Age of Sail
By Richard Windsor, The Week UK Published
-
How Britain's demographic is changing
The Explainer A 50-year record population increase was fuelled by greater migration
By Richard Windsor, The Week UK Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published